ADOCIA SAS (ADOC.PA) Stock Fundamental Analysis

EPA:ADOC • FR0011184241

6.52 EUR
-0.34 (-4.96%)
Last: Feb 25, 2026, 09:38 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, ADOC scores 2 out of 10 in our fundamental rating. ADOC was compared to 77 industry peers in the Biotechnology industry. ADOC may be in some trouble as it scores bad on both profitability and health. ADOC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ADOC had negative earnings in the past year.
  • ADOC had a negative operating cash flow in the past year.
  • ADOC had negative earnings in each of the past 5 years.
  • In the past 5 years ADOC always reported negative operating cash flow.
ADOC.PA Yearly Net Income VS EBIT VS OCF VS FCFADOC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -35.67%, ADOC is in line with its industry, outperforming 46.75% of the companies in the same industry.
Industry RankSector Rank
ROA -35.67%
ROE N/A
ROIC N/A
ROA(3y)-47.28%
ROA(5y)-53.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADOC.PA Yearly ROA, ROE, ROICADOC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

  • The Gross Margin of ADOC (79.22%) is better than 70.13% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ADOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADOC.PA Yearly Profit, Operating, Gross MarginsADOC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ADOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ADOC has been increased compared to 1 year ago.
  • The number of shares outstanding for ADOC has been increased compared to 5 years ago.
  • ADOC has a better debt/assets ratio than last year.
ADOC.PA Yearly Shares OutstandingADOC.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADOC.PA Yearly Total Debt VS Total AssetsADOC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ADOC has an Altman-Z score of 0.23. This is a bad value and indicates that ADOC is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ADOC (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACCN/A
WACC7.79%
ADOC.PA Yearly LT Debt VS Equity VS FCFADOC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • ADOC has a Current Ratio of 1.14. This is a normal value and indicates that ADOC is financially healthy and should not expect problems in meeting its short term obligations.
  • ADOC has a Current ratio of 1.14. This is in the lower half of the industry: ADOC underperforms 66.23% of its industry peers.
  • A Quick Ratio of 1.12 indicates that ADOC should not have too much problems paying its short term obligations.
  • ADOC's Quick ratio of 1.12 is on the low side compared to the rest of the industry. ADOC is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.12
ADOC.PA Yearly Current Assets VS Current LiabilitesADOC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.52% over the past year.
  • The Revenue has grown by 1879.16% in the past year. This is a very strong growth!
  • The Revenue has been growing by 34.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.8%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ADOC will show a very negative growth in Earnings Per Share. The EPS will decrease by -36.55% on average per year.
  • The Revenue is expected to decrease by -18.55% on average over the next years. This is quite bad
EPS Next Y-84.23%
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%
EPS Next 5Y-36.55%
Revenue Next Year-66.58%
Revenue Next 2Y-25.22%
Revenue Next 3Y-48.43%
Revenue Next 5Y-18.55%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ADOC.PA Yearly Revenue VS EstimatesADOC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
ADOC.PA Yearly EPS VS EstimatesADOC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ADOC. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 34.87 indicates a quite expensive valuation of ADOC.
  • Based on the Price/Forward Earnings ratio, ADOC is valued a bit cheaper than 79.22% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, ADOC is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 34.87
ADOC.PA Price Earnings VS Forward Price EarningsADOC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADOC.PA Per share dataADOC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ADOC's earnings are expected to decrease with -28.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ADOC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ADOCIA SAS

EPA:ADOC (2/25/2026, 9:38:12 AM)

6.52

-0.34 (-4.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-15
Earnings (Next)02-24
Inst Owners12.54%
Inst Owner ChangeN/A
Ins Owners3.53%
Ins Owner ChangeN/A
Market Cap127.86M
Revenue(TTM)10.35M
Net Income(TTM)-9.72M
Analysts84.44
Price Target15.5 (137.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)84.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-30.74%
Revenue NY rev (3m)-30.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.87
P/S 12.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)0.19
Fwd EY2.87%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0.53
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.22%
FCFM N/A
ROA(3y)-47.28%
ROA(5y)-53.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.43%
Cap/Sales 2.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.12
Altman-Z 0.23
F-Score4
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)32.19%
Cap/Depr(5y)28.97%
Cap/Sales(3y)3.68%
Cap/Sales(5y)12.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.8%
EPS Next Y-84.23%
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%
EPS Next 5Y-36.55%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A
Revenue Next Year-66.58%
Revenue Next 2Y-25.22%
Revenue Next 3Y-48.43%
Revenue Next 5Y-18.55%
EBIT growth 1Y47.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75.21%
EBIT Next 3Y-29.09%
EBIT Next 5YN/A
FCF growth 1Y-33.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.93%
OCF growth 3YN/A
OCF growth 5YN/A

ADOCIA SAS / ADOC.PA FAQ

What is the fundamental rating for ADOC stock?

ChartMill assigns a fundamental rating of 2 / 10 to ADOC.PA.


What is the valuation status of ADOCIA SAS (ADOC.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to ADOCIA SAS (ADOC.PA). This can be considered as Overvalued.


Can you provide the profitability details for ADOCIA SAS?

ADOCIA SAS (ADOC.PA) has a profitability rating of 1 / 10.


What is the financial health of ADOCIA SAS (ADOC.PA) stock?

The financial health rating of ADOCIA SAS (ADOC.PA) is 2 / 10.